Lapitan, Bernadine .
HRN: 28-17-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/11/2025
12/14/2025
IV
500mg
Q8h
S/P CS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes